Kristin Moore

Jul 25, 2024 | jamanetwork.com | Neil Shah |New jersey |Kristin Moore |Reshma Shinde

Key PointsQuestion  What are the health care resource use, associated costs, and clinical outcomes for patients with metastatic renal cell carcinoma (mRCC) receiving first-line ipilimumab plus nivolumab (I+N) or pembrolizumab plus axitinib (P+A)?

Apr 8, 2023 | jmig.org | Erin Carey |Kristin Moore |Asha B. MCCLURG |Ayana DEGAIA |Lauren SCHIFF

Study Objective To examine national trends among race and ethnicity and route of benign hysterectomy from 2007-2018. Design This is a retrospective analysis of the prospective National Surgical Quality Improvement Program (NSQIP) cohort program. Setting This study included data from the NSQIP database including data from the 2014-2018 targeted hysterectomy files. Patients Adult patients undergoing hysterectomy.